Home | Online Registration | Registration Form | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
AACL AACL AACL AACL
BSAAM Logo
AACL Logo
BSAAM's Anti Ageing Conference London 2017
Follow us on ...
Facebook  Twitter
Conference Information
2017 Program
2017 Speaker List
2017 Pre-Conference Workshops
2017 Exhibitors Form
2017 Press Form
2017 Peer Review Board Members
   
Delegate Information
Invitation Letter for Visas
2017 Registration Form
2017 VENUE: The Kensington Town Hall - MAP
Nearby London Accommodations
   
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
   
Past Conference Information
  2016
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAM's AACL 2016 Peer Review Board Members
  2015
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAM's AACL 2015 Peer Review Board Members
  2014
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
  2013
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
  2012
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
  2011
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
  2010
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
  2009
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
  2008
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  2006
  3rd Annual Anti-Ageing Conference Manual (2006)
Post Review, remarks and photos of 2006
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  2005
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  2004
  Past Speakers 2004
  2002
  Past Speakers Monte Carlo 2002
   
BSAAM's AACL Organizer
BSAAM
BSAAM Affiliates
waaam
   
   
A4M
   
wosaam
AACL Supporters
HB Health
www.hbhealth.com
   
CPD
   
  BANT
   
 
   
 
   
  Sun Chlorella
   
 
   
enerzona
   
BHMA
   
WOCPM
   
FACE
   
IAAS
   
Dole
   
 
   
 
   
   

AACL 2015 Speaker

Prof John G Ionescu PhD

Prof. Ionescu is Scientific Director and founder of the Special Clinic Neukirchen, located in 93453 Neukirchen, Germany. After graduation in biochemistry and immunology at the University of Bucharest, 1976 and a scientific fellowship in Montreal, Canada, Dr.Ionescu wandered to West-Germany and established there since 1980. He received his PhD in medical biochemistry 1983 from the University of Saarbrücken, Germany, and directed until 1985 the research programme of a dermatological clinic in Aschaffenburg. Main research areas included the atopic diseases, psoriasis, arthritis and the MCS-syndrome. Dr.Ionescu founded 1986 in Bavaria the Special Clinic Neukirchen (www.spezialklinik-neukirchen.de) for the treatment of allergic, skin and environmental diseases according to the principles of the nutritional and environmental medicine. His 160 bed facility is fully integrated in the official hospital system and the treatment fees are reimbursed by all German and Austrian health insurances. The original diagnostic and therapeutic approaches of his cortisone-, cytostatic- and radiation-free concept have been reported in more than 220 scientific publications in Germany, Europe and USA. Current work involves the investigation of biological redox systems and free radical reactions in skin, environmental and cancer patients. His research results are subjects of new methods for the rapid free radical and redox potential assessment in human blood samples, new dermatological formulations for the diseased and aging skin, patented anti-cancer drugs and original integrative protocols for the treatment of MCS, CFS and chronic dermatoses. Dr. Ionescu is member of the European Academy for Allergology and Clinical Immunology, of the American Academy of Anti-Aging Medicine, of the German Society of Environmental and Human Toxicology and of the German Society of Anti-Aging Medicine. Between 1998 and 2006 he served as Professor for Applied Laboratory Medicine at the Capital University of Integrative Medicine, Washington, D.C. (USA). From May 2006 until December 2010 Prof.Ionescu was appointed as Associate Professor for Gerontology at the University of Medicine and Pharmacy Carol Davila in Bucharest. Since April 2007 he is continuously acting as Visiting Professor for Nutritional Medicine at the Donau University, Krems/ Vienna. Since March 2009, he became a member of the Commission for Environmental Medicine of the Ministry of Health in Berlin. On February 2014 he was nominated as Associate Professor for Integrative Medicine at the Medical University Titu Maiorescu in Bucharest.

2015 - Personalized anti-inflammatory nutrition for allergic and auto-immune disorders

Our experience in the treatment of over 20,000 atopic eczema (AE), urticaria and autoimmune patients shows that besides allergic mechanisms an increasing number of pseudoallergic reactions caused by toxic-irritative pollutants (exhaust particles, solvents, pesticides, heavy metals) are responsible for the inflammatory process behind the symptoms. Intrauterine and postnatal influences of environmental factors have been also confirmed.
Besides the routine analysis of increased specific IgE- and IgG4-factors in our atopic patients after challenge meals (CM), inflammation markers like acute phase proteins (1 antitrypsin, 2 macroglobulin, haptoglobin and caeruloplasmin) showed a surprisingly rapid increase after CM in the atopic group, but not in healthy subjects.
Serum histamine levels (RIA-Test) showed a significant increase 1/2 hour after CM and after individual oral provocation with lactose, fructose, tyramine, serotonine or phenylethylamine. Accordingly, we noticed significantly reduced DAO and Type B MAO activities in thrombocyte–rich plasma of AE patients. In contrast, IgE-mediated reactions were absent in our scleroderma, lupus and rheumatoid arthritis patients; instead, a large number of positive food-specific IgG4, increased circulating immune complexes and cellular sensitization reactions (ALCAT Test) were recorded in these groups.
The carbohydrate intolerance reactions (H2-test) were in good correlation to the significantly lowered disaccharidase activites (lactase, maltase) in the gut of AE and autoimmune patients. This was closely related to chronic intestinal dysbiosis, leading to toxic microbial breakdown products (alcohols, aldehydes, phenols, diamines) and to an increased intestinal permeability, histamine release and impairment of liver detox functions.
Oral intake of different food homogenates/juices resulted in significant changes in the free radical generation in blood, according to their ROS-blocking or ROS-increasing effects.
Our recent research shows that appropriate combinations of hypoallergenic protein hydrolysates with sugar alcohols and -3 PUFAs (EQUIDERM PLUS®) are showing high free radical quenching and anti-inflammatory properties and a remarkable symptom alleviation in allergic and autoimmune patients.
With the emergence of affordable microarray gene expression profiling methods we had the opportunity to ex-vivo test certain nutraceutical combinations for their silencing ability on inflammatory genes before administering it to the patient (nutrigenomic evaluation). The input of the above mentioned nutritional data in a computer supported, individual rotation diet plan (FOOD ALLERGY CONTROL®) ensures a gradual improvement of the symptoms and stabilization of the clinical course during and after therapy.

2015 - Are vitamin C and polyphenols specifically killing cancer cells ?

The present work describes the immunbiological and therapeutic effects of Vitamin C and three different combinations of substituted phenolic compounds acting against hypoxic and normoxic cancer cells through their highly reactive intermediates and emerging reactive oxygen species. The phenolic mixtures in their semiquinone activated forms are known to decrease the hypoxic mediated accumulation of reductive equivalents, to increase the oxygen consumption and to restore the normal redox potentials and functionality in the hypoxic cells. Besides, the antitumour activity of the phenol / quinone containing drugs largely depends on the microsomal NADPH: quinone oxidoreductase activity conferring such compounds an increased tumor selectivity through the overexpressed enzyme in various tumor types. When oxidized to quinones, phenolic compounds are known to strongly accelerate NADPH-oxidation and oxygen consumption in the microsomal system of tumour cells and to form free radicals (superoxide). The ROS generating capability of the phenolic mixture was clearly demonstrated in blood and plasma after oral ingestion by means of a ultraweak chemoluminescence technology. Another free radical generating compound, Vitamin C is also part of a broad-spectrum antimicrobial, anti-inflammatory and immune modulating protocol, frequently used in patients with systemic microbial overload, fibromyalgia and malignant tumors. Both the phenolic compounds and Vitamin C are taking advantage on the diminished capability of tumor cells to handle free radicals. Whereas free radicals are quickly scavenged in normoxic (healthy) tissues, hypoxic tumour cells are expressing low levels of ROS protective enzymes like superoxide dismutase, catalase and GSH-peroxidase (GPx). Therefore, a depressed anti-ROS enzymatic equipment renders tumor cells much more sensitive to a free radical attack than normal cells. Finally, the antitumor activity of both Vitamin C and phenolic compounds is significantly potentiated by higher concentrations of transitional heavy metals like Fe, Pb, Cd, Cr, Ni and Hg as measured by us in breast cancer biopsies from the 1st Oncology Department of the Prague Medical School by means of Atomic Absorption Spectrophotometry. The autooxidation of Vitamin C and phenolic compounds in the presence of heavy metals strongly increases the superoxide and H2O2 formation resulting in a fast depletion of tumor cell reducing equivalents with oxidosis shift and apoptosis/necrosis induction. Our clinical results suggest that the use of the above mentioned pro-oxidative compounds devoid of side-effects is particularly promising in the treatment of different malignancies and infections.

Home | Online Registration | Registration Form | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :
london@antiageingconference.com
mariasomers@bsaam.com